baber/WOPTO huggingface dataset:
Patent JP-2569288-B2 (JP)
IPC: C08G77/46
Filed: 1994-12-15
Granted: 1997-01-08
Abstract: A method of defoaming diesel fuel by adding an organofunctionally modified polysiloxane of the general Formula I   <IMAGE>   wherein R1are alkyl groups with 1 to 4 carbon atoms or aryl groups with the proviso that at least 80% of the R1groups are methyl groups, R2 are the same or different in the molecule 30 to 90% of R2 having the same meaning as R1, and 70 to 10% of R2 consisting of a mixture of R2A and R2B groups which differ in polarity, is described. The inventive polysiloxane is added in an amount of 0.5 to 50 ppm, based on the diesel fuel.
Patent JP-3549111-B2 (JP)
IPC: A61P1/00
Filed: 1994-05-27
Granted: 2004-08-04
Abstract: The use of an alkaline salt of the (-)-enantiomer of omeprazole for the manufacture of a pharmaceutical preparation having improved pharmacokinetic and metabolic properties, such as improved therapeutic profile when treating gastric acid related diseases.
Patent JP-3811726-B2 (JP)
IPC: A61K31/4164
Filed: 1993-06-08
Granted: 2006-08-23
Abstract: A discovery underlying this invention is the concordance between particular cellular signaling mechanisms and cancer cell growth and metastasis. It has now been discovered that certain compounds inhibit the signal transduction required for the maintenance and driving of the malignant process. These compounds are also effective for the in vivo treatment of solid tumors and related disease states. This invention provides a method for the use of these compounds to inhibit the invasion and metastasis of malignant solid tumors in mammals. This invention further provides a method for using related compounds to treat diseases involving aberrant signal transduction pathways. Some of the compounds used in the methods of the present invention are novel and constitute another aspect of this invention.
Patent JP-2841304-B2 (JP)
IPC: C08L79/08
Filed: 1989-05-05
Granted: 1998-12-24
Abstract: PCT No. PCT/GB89/00477 Sec. 371 Date Nov. 2, 1990 Sec. 102(e) Date Nov. 2, 1990 PCT Filed May 5, 1989 PCT Pub. No. WO89/10948 PCT Pub. Date Nov. 16, 1989.A polymeric composition comprises: (i) an aromatic polyimide or an aromatic carboxylic ester polymer, (ii) a substantially wholly aliphatic polyamide, and (iii) a polyamide that contains both aromatic aliphatic moieties. It is found that the mechanical properties of blends of the aromatic polymers (i) and the polyamides (iii) can be significantly improved by the incorporation of a quantity of the aliphatic amides (ii), even though the miscibility of polymers, as observed by their glass transition temperatures may remain unchanged.
Patent JP-3278657-B2 (JP)
IPC: B41F15/08
Filed: 1992-03-06
Granted: 2002-04-30
Abstract: PCT No. PCT/GB92/00406 Sec. 371 Date Oct. 28, 1993 Sec. 102(e) Date Oct. 28, 1993 PCT Filed Mar. 6, 1992 PCT Pub. No. WO92/16090 PCT Pub. Date Sep. 17, 1992.A method and apparatus for use in printing which includes a print table mounted on a base frame, a support secured to the print table, a vision device secured to the support which is disposed such that the vision device uses a major face of the print table, securing a substrate to the print table, mounting a screen, a device for effecting relative movement between the print table and screen mounting from a first position in which the vision device can view fiducial marks carried by the substrate to a second position in which the screen is positioned between the vision device and the substrate, in which the vision device can view fiducial marks carried by the screen to facilitate the adjustment of relative positions of the screen and substrate so that the fiducial marks on the screen and substrate are in register.
Patent JP-H0733843-B2 (JP)
IPC: F16B13/12
Filed: 1987-09-03
Abstract: A multi-function integrally molded plastic fastener (10) for insertion within a hole in a wall for fastening objects to any of solid, thick or thin hollow walls. The fastener (10) comprises a base element (1) and an anchoring element with the base element (1) being positioned within the hole and depending whether the wall is solid, thick or thin hollow wall, the anchoring element is positioned totally within, partially within and totally behind the wall respectively. The anchoring element is comprised of outstretched anchoring arms (4) which are collapsible for insertion within the hole and which arms have interfitting sections of a sinusoidal wave configuration (10a, 11a, 10b, 11b) to minimize the cross section of the anchoring element and the width required for the hole. In preferred embodiment a stiffening rib (15) is interposed between wave crests (10a, 10b) and wave troughs (11a, 11b). The ends of the arms (9), spaced from the base element (1), engage an external fastening member (16) thereby providing a solid anchorage in any of a solid, thick or thin hollow wall. <IMAGE>
Patent JP-4184448-B2 (JP)
IPC: C21B13/00
Filed: 1998-07-03
Granted: 2008-11-19
Abstract: In a method for the production of liquid metal, in particular liquid pig iron (9) or liquid steel pre-products, from metal carriers, in particular partially reduced or reduced sponge iron (3), in a melter gasifier (1) in which with supply of a carbon-containing material at least partially formed of fine coal (16) and coal dust (13) and with supply of oxygen or oxygen-containing gas the metal carriers are melted in a bed (4) of the carbon-containing material at the simultaneous formation of a reducing gas, optionally upon previous final reduction, fine coal (16) and coal dust (13) which are being charged, are mixed with bitumen (20) in the hot state, after undergoing a drying operation, and subsequently are cold-briquetted, and the briquettes (25) thus formed are charged to the melter gasifier (1) in the cold state and in the melter gasifier (1) are subjected to shock-heating.
Patent JP-2528849-B2 (JP)
IPC: C12N1/16
Filed: 1986-11-24
Granted: 1996-08-28
Abstract: Improved secretion of heterologous proteins by hosts such as yeast by using promoters of at most intermediate strength with heterologous DNA secretion signal sequences is disclosed. A promoter of at most intermediate strength, such as the actin (ACT) or iso-1-cytochrome c (CYC1) promoter in S. cerevisiae is operatively linked to a DNA signal sequence, such as the Mf alpha 1 signal sequence. A DNA sequence for a selected protein, such as somatomedin C (SMC), tissue plasminogen activator (TPA) or tumor necrosis factor (TNF), may be operatively linked to the DNA signal sequence.
Patent JP-4484968-B2 (JP)
IPC: C12P21/08
Filed: 1997-08-01
Granted: 2010-06-16
Abstract: This invention relates to amino acid sequences from within a consensus peptide of the formula: VEKNITVTASVDPTIDLLQADGSALPSAVALTYSPA (Seq. #1). Eight mer peptides from within the consensus peptide were tested against an antibody raised to the consensus peptide. Studies relating to antibody raised to denatured proteins from the natural organisms producing the family of proteins were also useful and showed particular value of some sequences. A sequence of the formula ASVDPTIDLLQA (Seq. #2) was identified thereby. An enlarged sequence of the formula TVTASVDPTIDLLQAD (Seq. #3) is also especially interesting as are intermediate sequences such as sequences VTASVDPTIDLLQAD (Seq. #4), TASVDPTIDLLQAD (Seq. #5), and TASVDPTIDLLQA (Seq. #6) as being binding sites for antibodies raised to the denatured proteins.
Patent JP-3618761-B2 (JP)
IPC: B01D53/94
Filed: 1996-06-07
Granted: 2005-02-09
Abstract: The present invention is an improved catalytic filter material for use in removing contaminants such as NOx from a fluid stream. The filter of the present invention employs composite fibers of expanded polytetrafluoroethylene (PTFE) filled with catalytic particles. The composite fibers are chopped into staple fibers and made into a felt material. Preferably, the felt material is then laminated on at least one side with a protective microporous membrane. The combined filter removes both macro-particles, such as dust, from the filter stream before the dust can clog active catalytic sites and effectively catalytically coverts undesirable contaminants in the fluid stream to acceptable end products.
Patent JP-4285614-B2 (JP)
IPC: H04J3/00
Filed: 1995-10-05
Granted: 2009-06-24
Abstract: PCT No. PCT/FI95/00551 Sec. 371 Date Apr. 7, 1997 Sec. 102(e) Date Apr. 7, 1997 PCT Filed Oct. 5, 1995 PCT Pub. No. WO96/11533 PCT Pub. Date Apr. 18, 1996A signal detection method in a TDMA mobile system with co-channel interference and receivers implementing the method. In the method, a primary signal (r1) and at least one interfering co-channel signal (r2-rN) are received on the same TDMA channel (F1, TS3). The co-channel signals propagate through multipath channels (hL,1 . . . hL,N) independent of one another, which provide them with a unique wave form coding. In addition, the co-channel signals have different but known training sequences. The multipath channel estimates of the primary signal (r1) and the at least one interfering co-channel signal (r2-rN) are determined through the received training sequences. After this, the primary signal is detected by utilizing the transmission channel estimates of both the primary signal and the at least one interfering co-channel signal.
Patent JP-3552718-B2 (JP)
IPC: A61K47/48
Filed: 1991-07-01
Granted: 2004-08-11
Abstract: The instant invention provides a library of bio-oligomers of defined size and known composition, in which the library contains all of the possible sequences of the bio-oligomers, and a method of synthesis thereof. The bio-oligomers of the library may be peptides, nucleic acids, or a combination of the foregoing. The instant invention also provides methods to identify bio-oligomers from a library that demonstrate desired characteristics such as binding, bioactivity and catalytic activity. Thus the instant invention provides a unique and powerful method to identify a useful bio-oligomer sequences from a library more quickly than current state-of-the-art technology allows. Effector molecules for use in treatment or diagnosis of disease are also provided.
Patent JP-3557206-B2 (JP)
IPC: A61K47/48
Filed: 1993-12-06
Granted: 2004-08-25
Abstract: A process for the preparation of a conjugate between a poly (ethylene glycol) and a protein or glycoprotein, the process comprising specifically binding the domain to a specific binder, to shield the domain from the poly (ethylene glycol) in the following conjugating step, thereafter conjugating the poly (ethylene glycol) to the protein or glycoprotein, wherein conjugation of the poly (ethylene glycol) to the domain is avoided and thereafter releasing the specific binder from the domain without releasing the poly (ethylene glycol) from the protein or glycoprotein, wherein the protein or glycoprotein is other than a proteolytic enzyme selected from the group consisting of trypsin, urokinase, tissue plasminogen activator, plasmin, chymotrypsin, elastase and kallikrein.
Patent JP-2656153-B2 (JP)
IPC: H04K1/02
Filed: 1991-07-18
Granted: 1997-09-24
Abstract: A system for the authentication of mobile stations and base stations in a cellular communications network. The system includes an algorithm which generates not only a key dependent response to a random challenge, but also a temporary conversation key or call variable which may be used to encipher traffic in the network. To protect against clones in the network, the algorithm uses a rolling key which contains historical information. A bilateral authentication procedure may be used to update the rolling key and to generate a new conversation key.
Patent JP-3121342-B2 (JP)
IPC: C12P19/18
Filed: 1990-10-24
Granted: 2000-12-25
Abstract: A method for genetically engineering cells to produce soluble and secretable Golgi processing enzymes instead of naturally occurring membrane-bound enzymes. Cells are genetically engineered to express glycosyltransferases which lack both a membrane anchor and a retention signal. The resulting altered enzyme becomes soluble and secretable by the cell without losing its catalytic activity. Secretion of the soluble glycosyltransferase by the cell provides for increased production and simplified recovery of glycosyltransferases.
Patent JP-3313109-B2 (JP)
IPC: C09J177/00
Filed: 1991-10-08
Granted: 2002-08-12
Abstract: Described are moisture-setting polyamides containing reactive alkoxysilane groups. These polyamides have a low melt viscosity and can therefore be used, without plasticizers, as jointing compounds, fusion adhesives and/or sealing compounds. The polyamides are characterized in that the alkoxysilane groups they contain have general formula (I), in which n = 0, 1 or 2; R?1 to R?4 are non-reactive organic groups and R?3 can also be H, the alkoxysilane group being linked to the polyamide group (PA) by a carbon atom belonging to the polyamide group.
Patent JP-2854135-B2 (JP)
IPC: H01M2/02
Filed: 1991-09-03
Granted: 1999-02-03
Abstract: An improved method for sealing an electrochemical cell comprises applying radial forces to an expanded, upper portion of the cell casing. A resilient sealing member is located in the upper portion so that when the radial forces reduce the diameter of the expanded casing portion the sealing member is compressingly held in place.
Patent JP-3471359-B2 (JP)
IPC: A61F2/28
Filed: 1994-12-08
Granted: 2003-12-02
Abstract: Surgically implantable shaped materials, e.g., sheets, are fabricated from elongate bone particles, advantageously those that have been demineralized. The materials when applied to a bone repair site enhance or accelerate new bone ingrowth by any one of a variety of biological and/or mechanical mechanisms.
Patent JP-3710095-B2 (JP)
IPC: C12N5/10
Filed: 1994-01-26
Granted: 2005-10-26
Abstract: A process for growing a PRRSV in a tissue culture which is susceptible to infection and replication of PRRSV to an amount sufficient to protect animals against PRRS or be used in diagnosing PRRS or identifying the molecular structure of PRRSV for development of recombinant products, comprising inoculating the PRRSV onto the tissue culture and harvesting the replicated PRRSV.
Patent JP-3539689-B2 (JP)
IPC: A44B18/00
Filed: 1997-10-01
Granted: 2004-07-07
Abstract: A method and a device manufactures a fastening element with interlocking elements integrated with a backing. The interlocking elements are produced by introducing a thermoplastic into the gap between a pressure roller and a shaping roller. The shaping roller has a screen with cylindrical openings produced by etching, electroplating or a laser so that the finished interlocking elements result exclusively from hardening the thermoplastic, at least in part, in the openings, in the screen. This method allows preparation of the shaping roller at very low cost. In addition, a previously customary second method step in formation of the interlocking elements is eliminated.
Patent JP-4754660-B2 (JP)
IPC: A61K38/00
Filed: 1997-11-12
Granted: 2011-08-24
Abstract: The present invention provides a method for treating symptoms of diabetes in a diabetic subject which comprises administering to the subject a therapeutically effective amount of an agent which inhibits binding of advanced glycation endproducts to any receptor for advanced glycation endproducts so as to treat chronic symptoms of diabetes in the subject.
Patent JP-4804600-B2 (JP)
IPC: H04M3/523
Filed: 1998-03-26
Granted: 2011-11-02
Abstract: A multimedia telecommunication automatic call distribution center which allows access to the call center via a plurality of access means, including telephone (104) and data networks (112-113) to provide simultaneous voice, data, and video access, and ensures effective transparent spreading of agents (120) over different geographical locations. The automatic call distribution center of the present invention uses a multimedia automatic call distribution server (110) acting as connection manager for data network callers and provides for automatic caller identification.
Patent JP-4447660-B2 (JP)
IPC: C03C17/42
Filed: 1998-03-28
Granted: 2010-04-07
Abstract: A process for manufacturing surface-sealed hollow glass containers is characterised in that during the manufacturing process the hollow glass containers are coated with a water-based, silane-containing cold treatment product at the outlet area of the cooling furnace arranged after a machine for manufacturing hollow glass containers, and in that a second layer of a water-based cold treatment product which contains the following components is applied on said first layer: (I) a water-based organopolysiloxane-containing composition produced from alkoxysilanes bearing a functional group and alkoxysilanes selected among trialkoxysilanes, dialkoxysilanes and tetra-alkoxysilanes; and (II) a silicium-free component selected among waxes, partial fatty acid esters, fatty acids and/or surfactants. The thus produced hollow glass containers have an increased continued use resistance.
Patent ES-2178977-B2 (ES)
Title: Aparato con lampara empotrada para falsos techos
Inventor: MR MING-HUA HUNG
IPC: F21V3/00
Filed: 2001-09-11
Granted: 2004-01-01
Abstract: Aparato con lámpara empotrada para falsos techos con una base (1) fijada en el espacio que existe en el falso techo, en el que la base tiene una cubierta reflectante (5). Dentro de la cubierta reflectante y en su extremo superior hay un asiento fijo (4) y un soporte de lámpara fluorescente respectivamente. El soporte de la toma de corriente está formado por varias pestañas soporte fijas (22) dispuestas en la periferia de un zócalo (21). Sobre las diferentes pestañas soporte fijas se pueden instalar de uno a cuatro casquillos (26) y otras tantas bombillas fluorescentes (27). En el centro del zócalo (21) está situada una barra vertical central (23). La barra central llega hasta el extremo superior de la cubierta reflectante (5) donde existe un espacio para la disipación del calor y atraviesa la tulipa hueca (3) con forma esférica por el agujero base (11) de la base anteriormente descrita para conectar el extremo superior de la tulipa con el asiento fijo descrito. Así pues, el soporte de la toma de corriente de la lámpara, los casquillos de las bombillas y las bombillas están situados dentro del espacio de la tulipa. La tulipa puede tener diversos colores, además de su forma esférica, creando así una atmósfera fresca y emitiendo una luz armoniosa y suave.
Patent ES-2639644-B2 (ES)
Title: Procedimiento de estimación del ruido cerebral a través de imágenes ambiguas
Inventor: PISARCHIK ALEXANDER
IPC: A61B5/16
Filed: 2016-05-04
Granted: 2018-06-07
Abstract: Procedimiento de estimación del ruido cerebral a través de imágenes ambiguas que comprende los siguientes pasos:#- mostrar una imagen ambigua a un sujeto;#- aplicar un cambio continuo durante un tiempo T al parámetro de control responsable del cambio en la percepción de dos interpretaciones de dicha imagen,#- registrar la actividad cerebral de dicho sujeto a través de una magneto-encefalografía;#- calcular mediante un análisis espectral el tiempo {ta} entre dos interpretaciones de la imagen;#- representar la curva {ta}/T respecto a T para obtener el valor N en el que la curva se satura.
Patent AU-2001278905-B2 (AU)
Title: Synthetic erythropoiesis stimulating proteins
Inventor: BOTTI PAOLO
IPC: C07K17/08
Filed: 2001-07-12
Granted: 2004-12-16
Abstract: The present invention concerns methods and compositions for extending the technique of native chemical ligation of a wider range of peptides, polypeptides, other polymers and other molecules via an amide bond (see FIG. 1 ). The invention further provides methods and uses for such proteins and derivatized proteins. The invention is particularly suitable for use in the synthesis of optionally polymer-modified, synthetic bioactive proteins, and of pharmaceutical compositions that contain such proteins.
Patent AU-2002236549-B2 (AU)
Title: Catheter for removal of solids from surgical drains
Inventor: GILLINOV ALAN MARC
IPC: A61F2/958
Filed: 2001-11-02
Granted: 2005-11-10
Abstract: A catheter is provided for clearing surgical drains of solid and semi-solid material that collects in and obstructs the drains. The catheter has a solids removal member at its distal end. Preferably, the solids removal member is an inflatable balloon, a deployable umbrella member, a deployable spring, a slicer, or a fixed spring. The solids removal member is effective to aid removal of collected solids from the surgical drain. An aspiration port is also provided at the distal end of the catheter to remove or aspirate collected solids that are dislodged from the surgical drain by the solids removal member. A method for using such a catheter is also provided.
Patent AU-2002250173-B2 (AU)
Title: Composite bone marrow graft material with method and kit
Inventor: MUSCHLER GEORGE F
IPC: A61L27/00
Filed: 2002-02-26
Granted: 2006-02-02
Abstract: A composite bone marrow graft material is provided having an enriched population of uniformly distributed progenitor cells. The graft material includes clot material preferably derived from non-anticoagulated bone marrow aspirate, which significantly improves the efficacy of the graft. A method for preparing such bone graft material is also provided. A kit is also provided containing sterilized implements useful in preparing enriched composite bone marrow graft material.
Patent AU-2002256361-B2 (AU)
Title: Coumarin derivatives to be used as anticoagulants
Inventor: DRUZGALA PASCAL
IPC: A61P7/02
Filed: 2002-04-24
Granted: 2008-01-24
Abstract: This invention is drawn to compounds which are more easily metabolized by the metabolic drug detoxification systems. Particularly, warfarin analogs which have been designed to include esters within the structure of the compounds are taught. The invention teaches methods of reducing the toxicity of drugs comprising the introduction of ester groups into drugs during the synthesis of the drug. This invention is also drawn to methods of treating coagulation disorders comprising the administration of compounds which have been designed to be metabolized by serum or intracellular hydrolases and esterases. Pharmaceutical compositions of the ester containing warfarin, analogs are also taught.
Patent AU-2002311926-B2 (AU)
Title: Method of forming an aerosol for inhalation delivery
Inventor: MYERS DANIEL J
IPC: A61K9/00
Filed: 2002-05-13
Granted: 2007-12-06
Abstract: Inhalation delivery of aerosols containing small particles is described. Specifically, it relates to a device that forms drug containing aerosols for use in inhalation therapy. In a device aspect of the present disclosure, a device for delivering drug containing aerosols for inhalation therapy is provided. The device includes a housing and an airway that has a gas/vapor mixing airway. The airway further includes a subassembly, which has a metallic substrate coated on its surface with a composition comprising a drug.
Patent AU-2002315374-B2 (AU)
Title: Osmotic implant with membrane and membrane retention means
Inventor: SCOTT GILBERT J
IPC: A61K9/22
Filed: 2002-06-21
Granted: 2008-07-24
Abstract: An osmotic delivery system for controlled delivery of a beneficial agent includes an implantable capsule containing a beneficial agent and an osmotic engine that swells on contact with water, thereby causing the release of the beneficial agent over time. The osmotic delivery system has a membrane material that allows a controlled amount of fluid to enter from an exterior of the capsule, while preventing the compositions within the capsule from passing out of the capsule. The osmotic delivery system is designed to meet at least the operating pressures of 1000 psi. The membrane material is cast, calendered or extruded followed by machining (i.e., die-cutting, stamping or otherwise cutting to shape) to provide a uniform nonribbed membrane material. The capsule also includes a membrane material-retaining means that is positioned at a fluid uptake end to retain the membrane material within the capsule, even under periods of high pressure.